🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Sellers market the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.

Several experts stated the popularity for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or prison.

Service Reaction and Content Removal

According to TikTok, the platform has removed problematic material and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also found groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, positive reviews and step-by-step guides for mixing or administering at residence.

Within moments of entering one group, a vendor posted contact information, where the majority of purchases occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.

Item Information and Pricing

Inside these communities, posts show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service stated it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is valid, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet approved … may expose patients to potentially significant health risks”.